Sun Pharmaceutical Industries Limited, also known as Sun Pharma, is a Mumbai-based multinational pharmaceutical company. It is known for producing and distributing pharmaceutical formulations and active pharmaceutical ingredients worldwide, serving over 100 countries.
Sun Pharma was founded by Dilip Shanghvi in 1983 in Vapi, Gujarat. They started with 5 products to treat mental health disorders. Later, it went on to introduce products for Cardiology in 1987.
Two years down the line, they released major Gastroenterology products in 1989.
They established their first-ever research center in 1991. With the help of robust groundwork, it laid a strong foundation for vital products and process development. This paved the way for massive growth in the subsequent years.
Later in 2007, the research center grew so big that it demerged from the parent company and got listed as Sun Pharma Advanced Research company.
A big acquisition ticks a box of great entrepreneurial skill. The good news was on the way for the pharmaceutical stalwarts.
The much-awaited news came in 2014. Sun Pharma acquired Ranbaxy making it the largest Indian Pharma company.
Sun Pharma generates a considerable 72% of its sales from international markets, indicating a strong global presence. Out of this, the US is the single most expansive market and accounts for 30% of the company’s turnover.
The manufacturing processes are carried out in 44 different regions.
Sun Pharma started trading in the stock exchange in 1994 and the IPO issue was over-subscribed by 55 times. Even today, the promoter’s family holds the majority of the company’s stake.
Today, Sun Pharma is a dominant player in the pharmaceutical sector and the largest in India. They are the fourth-largest specialty generic pharmaceutical company in the world. Dilip Shanghvi(Founder & MD), when asked about the company’s future vision, said “I don’t have the ability to predict the long-term future because there are a large number of variables. However, our focus has always been that each of our businesses should focus on improving its performance over what we did last year. If I look at our major businesses—India, global specialty, and generics businesses in the US and Europe, emerging markets and Japan—I’m expecting each of these businesses to do better than last year. It’s only because we keep on improving consistently year after year and we continue to grow faster than the industry. At the same time, we also make research and development (R&D) investments in such a way that some of them produce short-term returns and some produce mid-term returns. And when long-term returns start, it is a step change in terms of the company’s growth. We’ve been making large investments in the specialty business over the past five years, and we are at a position where it will start contributing to the profitability and future growth of the company in a much more meaningful way.”
Sun Pharma Share Price History
| Year | Share Price | Gain / Loss |
|---|---|---|
| 1995 | ₹ 1.60 | |
| 1996 | ₹ 1.59 | - 0.6% |
| 1997 | ₹ 1.49 | - 6.3% |
| 1998 | ₹ 1.84 | + 23.5% |
| 1999 | ₹ 11.50 | + 525.0% |
| 2000 | ₹ 10.84 | - 5.7% |
| 2001 | ₹ 12.72 | + 17.3% |
| 2002 | ₹ 13.36 | + 5.0% |
| 2003 | ₹ 26.43 | + 97.8% |
| 2004 | ₹ 49.24 | + 86.3% |
| 2005 | ₹ 60.58 | + 23.0% |
| 2006 | ₹ 86.94 | + 43.5% |
| 2007 | ₹ 121.20 | + 39.4% |
| 2008 | ₹ 106.50 | - 12.1% |
| 2009 | ₹ 150.71 | + 41.5% |
| 2010 | ₹ 242.32 | + 60.8% |
| 2011 | ₹ 248.43 | + 2.5% |
| 2012 | ₹ 367.75 | + 48.0% |
| 2013 | ₹ 567.75 | + 54.4% |
| 2014 | ₹ 826.15 | + 45.5% |
| 2015 | ₹ 819.95 | - 0.8% |
| 2016 | ₹ 629.75 | - 23.2% |
| 2017 | ₹ 570.80 | - 9.4% |
| 2018 | ₹ 430.65 | - 24.6% |
| 2019 | ₹ 432.50 | + 0.4% |
| 2020 | ₹ 591.35 | + 36.7% |
| 2021 | ₹ 845.40 | + 43.0% |
| 2022 | ₹ 1,000.70 | + 18.4% |
| 2023 | ₹ 1,260.05 | + 25.9% |
| 2024 | ₹ 1,805.60 | + 43.3% |
Sun Pharma Share Price Chart
Click here for high resolution Sun Pharma Share Price chart
Sun Pharma Share Returns Calculator
Enter any amount in the 'Investment amount' field and select a year.
The Sun Pharma calculator will tell you the value of your Sun Pharma investment in 2024.
Invested Amount
Investment Year
- During 1995, the share price of Sun Pharma was ₹ 1.6.
- If you had bought shares worth ₹ 2500 in 1995, you would have 15625 shares today.
- At the end of 2024, the current value of your shares would be ₹ 28212500.
Sun Pharma Share Returns Comparison
Invested Amount
Investment Year
Other Investment
Interest Rate